Alerts will be sent to your verified email
Verify Email
MAHAREM
|
IndoAmerican Advance
|
Aarey Drugs & Pharma
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-12.16 % | 5.07 % | -352.38 % |
|
5yr Avg Net Profit Margin
|
-36.65 % | 1.44 % | -2.03 % |
|
Price to Book
|
n/a | 1.29 | 0.0 |
|
P/E
|
n/a | 42.95 | 18.66 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 77.34 Days | 28.76 Days |
|
5yr Average Interest Coverage Ratio
|
-55.68 | 4.14 | 0.28 |
|
5yr Avg ROCE
|
-12.15 % | 8.93 % | -0.98 % |
|
5yr Avg Operating Profit Margin
|
-72.03 % | 1.54 % | 1.32 % |
|
5 yr average Debt to Equity
|
0.0 | 0.21 | 29.7 |
|
5yr CAGR Net Profit
|
n/a | -4.17 % | n/a |
|
5yr Average Return on Assets
|
-11.02 % | 2.26 % | -2.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.97 % | 44.8 % | 74.94 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.4 % | -5.23 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
IndoAmerican Advance
|
Aarey Drugs & Pharma
|
Kimia Biosciences
|
|---|